Dengue hemorrhagic fever
ICD-10 A96.0 is a billable code used to indicate a diagnosis of dengue hemorrhagic fever.
Dengue hemorrhagic fever (DHF) is a severe form of dengue fever, a viral illness transmitted by Aedes mosquitoes, primarily Aedes aegypti. It is characterized by high fever, hemorrhagic manifestations, and increased vascular permeability leading to plasma leakage, which can result in shock and organ failure. The clinical presentation often includes symptoms such as severe abdominal pain, persistent vomiting, and bleeding tendencies, which may manifest as petechiae, gum bleeding, or gastrointestinal bleeding. DHF typically occurs in individuals who have had a previous dengue infection, as the immune response can exacerbate the disease severity. Diagnosis is confirmed through serological tests or PCR, and management focuses on supportive care, including fluid replacement and monitoring for complications. Travel history to endemic areas is crucial for diagnosis, as DHF is prevalent in tropical and subtropical regions. Early recognition and intervention are vital to prevent severe outcomes.
Detailed clinical notes on symptoms, travel history, and lab results.
Patients presenting with fever and bleeding after travel to endemic regions.
Ensure accurate documentation of previous dengue infections and any complications.
Immediate assessment notes, including vital signs and initial lab results.
Patients with acute febrile illness and signs of shock.
Timely documentation is critical for coding and billing, especially in acute settings.
Used to confirm diagnosis in patients with suspected dengue hemorrhagic fever.
Document the reason for testing and clinical symptoms.
Infectious disease specialists should ensure comprehensive lab documentation.
Key symptoms include high fever, severe abdominal pain, persistent vomiting, bleeding tendencies, and signs of shock. Early recognition is crucial for management.
